Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Radiography, CT, and MRI of Hip and Lower Limb Disorders in Children and Adolescents.

Silva MS, Fernandes ARC, Cardoso FN, Longo CH, Aihara AY.

Radiographics. 2019 May-Jun;39(3):779-794. doi: 10.1148/rg.2019180101.

PMID:
31059403
2.

Blood Flow Restriction Does Not Attenuate Short-Term Detraining-Induced Muscle Size and Strength Losses After Resistance Training With Blood Flow Restriction.

Teixeira EL, de Salles Painelli V, Silva-Batista C, de Souza Barros T, Longo AR, Lasevicius T, Schoenfeld BJ, Aihara AY, de Almeida Peres B.

J Strength Cond Res. 2019 Apr 11. doi: 10.1519/JSC.0000000000003148. [Epub ahead of print]

PMID:
31009425
3.

Erratum to 'Femoral Component Axial Rotation in the Gap-Balancing Approach to Total Knee Arthroplasty: Measurement by Computed Tomography' [The Journal of Arthroplasty 33 (2018) 1222-1230].

Aihara AY, Cardoso FN, Debiex P, Castro AM, Luzo MVM, Fernandes ARC.

J Arthroplasty. 2019 Apr;34(4):816-817. doi: 10.1016/j.arth.2018.12.031. Epub 2019 Jan 23. No abstract available.

PMID:
30683540
4.

The development of the anterior cruciate ligament in the paediatric population.

Lima FM, Debieux P, Astur DC, Luzo MVM, Cohen M, Cardoso FN, Aihara AY, Grimberg A, Fernandes ARC.

Knee Surg Sports Traumatol Arthrosc. 2019 Jan 22. doi: 10.1007/s00167-019-05349-x. [Epub ahead of print]

PMID:
30671598
5.

Cognitive map to support the diagnosis of solitary bone tumors in pediatric patients.

Moreira FC, Aihara AY, Lederman HM, Pisa IT, Tenório JM.

Radiol Bras. 2018 Sep-Oct;51(5):297-302. doi: 10.1590/0100-3984.2017.0121.

6.

Different Patterns in Muscular Strength and Hypertrophy Adaptations in Untrained Individuals Undergoing Nonperiodized and Periodized Strength Regimens.

De Souza EO, Tricoli V, Rauch J, Alvarez MR, Laurentino G, Aihara AY, Cardoso FN, Roschel H, Ugrinowitsch C.

J Strength Cond Res. 2018 May;32(5):1238-1244. doi: 10.1519/JSC.0000000000002482.

PMID:
29683914
7.

Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs.

Ueda H, Akiyama Y, Shimada S, Mogushi K, Serizawa M, Matsumura S, Mitsunori Y, Aihara A, Ban D, Ochiai T, Kudo A, Tanabe M, Tanaka S.

Endocr Relat Cancer. 2018 Jun;25(6):619-631. doi: 10.1530/ERC-17-0328. Epub 2018 Mar 29.

PMID:
29599123
8.

Novel 3D Liquid Cell Culture Method for Anchorage-independent Cell Growth, Cell Imaging and Automated Drug Screening.

Abe-Fukasawa N, Otsuka K, Aihara A, Itasaki N, Nishino T.

Sci Rep. 2018 Feb 26;8(1):3627. doi: 10.1038/s41598-018-21950-5.

9.

Different Patterns in Muscular Strength and Hypertrophy Adaptations in Untrained Individuals Undergoing Non-Periodized and Periodized Strength Regimens.

De Souza EO, Tricoli V, Rauch A, Alvarez MR, Laurentino G, Aihara AY, Cardoso FN, Roschel H, Ugrinowitsch C.

J Strength Cond Res. 2018 Jan 29. doi: 10.1519/JSC.0000000000002482. [Epub ahead of print]

PMID:
29385004
10.

Distal myopathy due to BICD2 mutations.

Souza PVS, Pinto WBVR, Aivazoglou LU, Cardoso FN, Aihara AY, Yamada AF, Naylor FGM, Fernandes ARC, Oliveira ASB.

Clin Neurol Neurosurg. 2018 Feb;165:47-49. doi: 10.1016/j.clineuro.2017.12.023. Epub 2017 Dec 29. No abstract available.

PMID:
29306765
11.

Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells.

Aihara A, Koike T, Abe N, Nakamura S, Sawaguchi A, Nakamura T, Sugimoto N, Nakauchi H, Nishino T, Eto K.

Blood Adv. 2017 Feb 28;1(7):468-476. doi: 10.1182/bloodadvances.2016000844. eCollection 2017 Feb 28.

12.

Femoral Component Axial Rotation in the Gap-Balancing Approach to Total Knee Arthroplasty: Measurement by Computed Tomography.

Aihara AY, Cardoso FN, Debiex P, Castro AM, Luzo MVM, Fernandes ARC.

J Arthroplasty. 2018 Apr;33(4):1222-1230.e2. doi: 10.1016/j.arth.2017.10.038. Epub 2017 Dec 8. Erratum in: J Arthroplasty. 2019 Apr;34(4):816-817.

PMID:
29224991
13.

Effects of different strength training frequencies during reduced training period on strength and muscle cross-sectional area.

Tavares LD, de Souza EO, Ugrinowitsch C, Laurentino GC, Roschel H, Aihara AY, Cardoso FN, Tricoli V.

Eur J Sport Sci. 2017 Jul;17(6):665-672. doi: 10.1080/17461391.2017.1298673. Epub 2017 Mar 19.

PMID:
28316261
14.

Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma.

Ohata Y, Shimada S, Akiyama Y, Mogushi K, Nakao K, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Tanabe M, Tanaka S.

Mol Cancer Ther. 2017 Jun;16(6):1155-1165. doi: 10.1158/1535-7163.MCT-16-0728. Epub 2017 Feb 28.

15.

ARID2 modulates DNA damage response in human hepatocellular carcinoma cells.

Oba A, Shimada S, Akiyama Y, Nishikawaji T, Mogushi K, Ito H, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Asahara H, Kaida A, Miura M, Tanabe M, Tanaka S.

J Hepatol. 2017 May;66(5):942-951. doi: 10.1016/j.jhep.2016.12.026. Epub 2017 Feb 24.

PMID:
28238438
16.

Preoperative direct bilirubin to prothrombin time ratio index to prevent liver failure after minor hepatectomy.

Furuyama T, Kudo A, Matsumura S, Mitsunori Y, Aihara A, Ban D, Ochiai T, Tanaka S, Tanabe M.

J Hepatobiliary Pancreat Sci. 2016 Dec;23(12):763-770. doi: 10.1002/jhbp.400. Epub 2016 Oct 12.

PMID:
27717165
17.

Novel 3-D cell culture system for in vitro evaluation of anticancer drugs under anchorage-independent conditions.

Aihara A, Abe N, Saruhashi K, Kanaki T, Nishino T.

Cancer Sci. 2016 Dec;107(12):1858-1866. doi: 10.1111/cas.13095. Epub 2016 Dec 19.

18.

Imaging evaluation of bone tumors.

Aihara AY.

Radiol Bras. 2016 May-Jun;49(3):VII. doi: 10.1590/0100-3984.2016.49.3e2. No abstract available.

19.

Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.

Huang CK, Aihara A, Iwagami Y, Yu T, Carlson R, Koga H, Kim M, Zou J, Casulli S, Wands JR.

Cancer Lett. 2016 Sep 28;380(1):153-62. doi: 10.1016/j.canlet.2016.05.038. Epub 2016 Jun 27.

20.

Proteasome activity is required for the initiation of precancerous pancreatic lesions.

Furuyama T, Tanaka S, Shimada S, Akiyama Y, Matsumura S, Mitsunori Y, Aihara A, Ban D, Ochiai T, Kudo A, Fukamachi H, Arii S, Kawaguchi Y, Tanabe M.

Sci Rep. 2016 May 31;6:27044. doi: 10.1038/srep27044.

21.

Molecular pathology of advanced hepatocellular carcinoma.

Aihara A, Wands JR, Tanaka S.

Nihon Shokakibyo Gakkai Zasshi. 2016 May;113(5):790-7. doi: 10.11405/nisshoshi.113.790. Japanese. No abstract available.

PMID:
27151475
22.

Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.

Huang CK, Iwagami Y, Aihara A, Chung W, de la Monte S, Thomas JM, Olsen M, Carlson R, Yu T, Dong X, Wands J.

PLoS One. 2016 Mar 8;11(3):e0150336. doi: 10.1371/journal.pone.0150336. eCollection 2016.

23.

Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm.

Katsuta E, Kudo A, Akashi T, Mitsunori Y, Matsumura S, Aihara A, Ban D, Ochiai T, Tanaka S, Eishi Y, Tanabe M.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1299-306. doi: 10.1007/s00432-016-2128-1. Epub 2016 Feb 17.

PMID:
26885661
24.

Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.

Ito H, Tanaka S, Akiyama Y, Shimada S, Adikrisna R, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Yamaoka S, Tanabe M.

PLoS One. 2016 Jan 14;11(1):e0146564. doi: 10.1371/journal.pone.0146564. eCollection 2016.

25.

Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.

Akahoshi K, Tanaka S, Mogushi K, Shimada S, Matsumura S, Akiyama Y, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Tanabe M.

J Gastroenterol. 2016 Sep;51(9):910-22. doi: 10.1007/s00535-015-1159-8. Epub 2016 Jan 6.

PMID:
26739296
26.

CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.

Katsuta E, Tanaka S, Mogushi K, Shimada S, Akiyama Y, Aihara A, Matsumura S, Mitsunori Y, Ban D, Ochiai T, Kudo A, Fukamachi H, Tanaka H, Nakayama K, Arii S, Tanabe M.

Int J Oncol. 2016 Feb;48(2):657-69. doi: 10.3892/ijo.2015.3299. Epub 2015 Dec 18.

PMID:
26691441
27.

Effects of exercise intensity and occlusion pressure after 12 weeks of resistance training with blood-flow restriction.

Lixandrão ME, Ugrinowitsch C, Laurentino G, Libardi CA, Aihara AY, Cardoso FN, Tricoli V, Roschel H.

Eur J Appl Physiol. 2015 Dec;115(12):2471-80. doi: 10.1007/s00421-015-3253-2. Epub 2015 Sep 1.

PMID:
26323350
28.

The difficulty of laparoscopic liver resection.

Ban D, Kudo A, Ito H, Mitsunori Y, Matsumura S, Aihara A, Ochiai T, Tanaka S, Tanabe M, Itano O, Kaneko H, Wakabayashi G.

Updates Surg. 2015 Jun;67(2):123-8. doi: 10.1007/s13304-015-0302-7. Epub 2015 Jul 10. Review.

PMID:
26160064
29.

Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.

Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gotohda N, Hatano E, Tanahashi Y, Mizuguchi T, Kamiyama T, Ikeda T, Tanaka S, Taniai N, Baba H, Tanabe M, Kokudo N, Konishi M, Uemoto S, Sugioka A, Hirata K, Taketomi A, Maehara Y, Kubo S, Uchida E, Miyata H, Nakamura M, Kaneko H, Yamaue H, Miyazaki M, Takada T.

J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):721-7. doi: 10.1002/jhbp.276. Epub 2015 Jul 1.

PMID:
26096910
30.

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.

Nakao K, Tanaka S, Miura T, Sato K, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Tanabe M.

Cancer Sci. 2015 Aug;106(8):1016-22. doi: 10.1111/cas.12701. Epub 2015 Jun 25.

31.

A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma.

Matsunaga H, Tanaka S, Aihara A, Ogawa K, Matsumura S, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Arii S, Tanabe M.

Ann Surg Oncol. 2015 Sep;22(9):3079-86. doi: 10.1245/s10434-014-4292-3. Epub 2014 Dec 19.

PMID:
25524010
32.

Advances in reduced port laparoscopic liver resection.

Ban D, Kudo A, Irie T, Ochiai T, Aihara A, Matsumura S, Tanaka S, Tanabe M.

Asian J Endosc Surg. 2015 Feb;8(1):11-5. doi: 10.1111/ases.12164. Epub 2014 Dec 15. Review.

PMID:
25510567
33.

Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype.

Dong X, Lin Q, Aihara A, Li Y, Huang CK, Chung W, Tang Q, Chen X, Carlson R, Nadolny C, Gabriel G, Olsen M, Wands JR.

Oncotarget. 2015 Jan 20;6(2):1231-48.

34.

Early adaptations to six weeks of non-periodized and periodized strength training regimens in recreational males.

Souza EO, Ugrinowitsch C, Tricoli V, Roschel H, Lowery RP, Aihara AY, Leão AR, Wilson JM.

J Sports Sci Med. 2014 Sep 1;13(3):604-9. eCollection 2014 Sep.

35.

A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.

Aihara A, Huang CK, Olsen MJ, Lin Q, Chung W, Tang Q, Dong X, Wands JR.

Hepatology. 2014 Oct;60(4):1302-13. doi: 10.1002/hep.27275. Epub 2014 Aug 25.

36.

Changes in exercises are more effective than in loading schemes to improve muscle strength.

Fonseca RM, Roschel H, Tricoli V, de Souza EO, Wilson JM, Laurentino GC, Aihara AY, de Souza Leão AR, Ugrinowitsch C.

J Strength Cond Res. 2014 Nov;28(11):3085-92. doi: 10.1519/JSC.0000000000000539.

PMID:
24832974
37.

LRH1 promotes pancreatic cancer metastasis.

Lin Q, Aihara A, Chung W, Li Y, Chen X, Huang Z, Weng S, Carlson RI, Nadolny C, Wands JR, Dong X.

Cancer Lett. 2014 Aug 1;350(1-2):15-24. doi: 10.1016/j.canlet.2014.04.017. Epub 2014 Apr 24.

PMID:
24769073
38.

Effective elimination of contaminants after oral care in elderly institutionalized individuals.

Ikeda M, Miki T, Atsumi M, Inagaki A, Mizuguchi E, Meguro M, Kanamori D, Nakagawa K, Watanabe R, Mano K, Aihara A, Hane Y, Mutoh T, Matsuo K.

Geriatr Nurs. 2014 Jul-Aug;35(4):295-9. doi: 10.1016/j.gerinurse.2014.03.003. Epub 2014 Apr 20.

PMID:
24755196
39.

LRH1 as a driving factor in pancreatic cancer growth.

Lin Q, Aihara A, Chung W, Li Y, Huang Z, Chen X, Weng S, Carlson RI, Wands JR, Dong X.

Cancer Lett. 2014 Apr 1;345(1):85-90. doi: 10.1016/j.canlet.2013.11.014. Epub 2013 Dec 11.

40.

Favorable response after gemcitabine-radiotherapy for invasive pancreatic intraductal papillary mucinous neoplasm: a case report.

Ochiai T, Igari K, Furuyama T, Ito H, Mitsunori Y, Aihara A, Kumagai Y, Iida M, Odajima H, Tanaka S, Arii S, Yamazaki S.

Int Surg. 2013 Oct-Dec;98(4):340-5. doi: 10.9738/INTSURG-D-13-00031.1.

41.

High resectability of colorectal liver metastases with aggressive chemotherapy in the era of molecular target-based agents.

Ochiai T, Ohta K, Iida M, Kumagai Y, Mitsunori Y, Aihara A, Noguchi N, Tanaka S, Arii S, Yamazaki S.

Hepatogastroenterology. 2013 Jul-Aug;60(125):955-60. doi: 10.5754/hge121213.

PMID:
23803362
42.

Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

Muramatsu S, Tanaka S, Mogushi K, Adikrisna R, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Nakayama K, Tanaka H, Yamaoka S, Arii S.

Hepatology. 2013 Jul;58(1):218-28. doi: 10.1002/hep.26345. Epub 2013 May 27.

PMID:
23447025
43.

Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance.

Sato K, Tanaka S, Mitsunori Y, Mogushi K, Yasen M, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Tanaka H, Arii S.

Hepatology. 2013 Apr;57(4):1436-47. doi: 10.1002/hep.26122. Epub 2013 Jan 25.

PMID:
23150500
44.

Reliability of airway occlusion pressure as an index of respiratory motor output.

Kera T, Aihara A, Inomata T.

Respir Care. 2013 May;58(5):845-9. doi: 10.4187/respcare.01717.

45.

Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.

Ochiai T, Masuda T, Yagi M, Kasai R, Furuyama T, Tsukamoto K, Ito H, Igari K, Aihara A, Kumagai Y, Iida M, Odajima H, Tanaka S, Arii S, Yamazaki S.

Int Surg. 2012 Jan-Mar;97(1):6-13. doi: 10.9738/CC88.1.

46.

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.

Mayinuer A, Yasen M, Mogushi K, Obulhasim G, Xieraili M, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Ann Surg Oncol. 2013 Jan;20(1):305-17. doi: 10.1245/s10434-012-2395-2. Epub 2012 Oct 13.

47.

Molecular adaptations to concurrent training.

de Souza EO, Tricoli V, Roschel H, Brum PC, Bacurau AV, Ferreira JC, Aoki MS, Neves M Jr, Aihara AY, da Rocha Correa Fernandes A, Ugrinowitsch C.

Int J Sports Med. 2013 Mar;34(3):207-13. doi: 10.1055/s-0032-1312627. Epub 2012 Oct 8.

PMID:
23044732
48.

Multivariate analysis in the maximum strength performance.

de Souza EO, Tricoli V, Paulo AC, Silva-Batista C, Cardoso RK, Brum PC, Bacurau AV, Laurentino G, Neves M Jr, Aihara AY, Ugrinowitsch C.

Int J Sports Med. 2012 Dec;33(12):970-4. doi: 10.1055/s-0032-1314813. Epub 2012 Aug 15.

PMID:
22895875
49.

Decreased Mrp2 transport in severe macrovesicular fatty liver grafts.

Kudo A, Ban D, Aihara A, Irie T, Ochiai T, Nakamura N, Tanaka S, Arii S.

J Surg Res. 2012 Dec;178(2):915-21. doi: 10.1016/j.jss.2012.04.057. Epub 2012 May 14.

PMID:
22613706
50.

Prognoses of GEP-NETS with undetermined malignant potentials of their primary sites.

Kudo A, Ban D, Akashi T, Kumagai J, Aihara A, Inokuchi M, Kojima K, Kawano T, Tanaka S, Arii S.

Hepatogastroenterology. 2012 Sep;59(118):1682-6. doi: 10.5754/hge12275.

PMID:
22584425

Supplemental Content

Loading ...
Support Center